Cyprus
Tuberculosis profile
Population  2012 1.1 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) <0.01 (<0.01–<0.01) 0.2 (0.16–0.25)
Mortality (HIV+TB only)        
Prevalence  (includes HIV+TB) 0.069 (0.021–0.15) 6.1 (1.8–13)
Incidence  (includes HIV+TB) 0.061 (0.053–0.069) 5.4 (4.7–6.1)
Incidence (HIV+TB only)        
Case detection, all forms (%) 100 (92–120)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 15 (28) Relapse 0 (0)
Smear-negative 9 (17) Treatment after failure 0 (0)
Smear-unknown / not done 19 (35) Treatment after default 0 (0)
Extrapulmonary 11 (20) Other 6 (100)
Other 0 (0)      
Total new 54   Total retreatment 6  
           
Other (history unknown) 9        
Total new and relapse 54   Total cases notified 69  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.1 1.8 0.8
Age < 15 0 1 0
Laboratories 2012
Is second-line drug susceptibility testing available?  
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 64   Is rifampicin used
throughout treatment for
new patients?
 
New smear-negative/extrapulmonary 64  
Retreatment 100  
TB/HIV 2012 Number (%)
TB patients with known HIV status    
HIV-positive TB patients    
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 4 (0.1–20) 0 (0–84)
MDR-TB cases among notified pulmonary
TB cases
2 (0–9) 0 (0–5)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 40 (93%) 2 (33%) 49
Laboratory-confirmed MDR-TB cases 0 0 0
Patients started on MDR-TB treatment      
Financing TB control 2013
National TB programme budget (US$ millions)  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-16 Data: www.who.int/tb/data